EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

One-Shot Rational Design of Covalent Drugs with CovalentLab

Xi Xue, Xiangying Liu, Xue Liu, Hanyu Sun, Shize Li, Kai Chen, Hanmiao Xu, Liangning Li, Chengxia Mao, Jingjie Yan, Peilan Yang, Baolian Wang und 3 weitere

JACS Au · 24.11.2025 · 5 (11) · 5676-5689

DOI: 10.1021/jacsau.5c01161 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACS Au, online erschienen am 03.11.2025. Verfasst von Xi Xue und 14 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Peking Union Medical College and Chines…. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Natural Science Foundation of Beijing Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted covalent drugs have demonstrated remarkable potential in disease treatment over the past decades. However, existing methods for covalent drug design are often limited to serine and cysteine, ignoring other potentially ligandable binding sites. Statistical analyses indicate that over 95% of binding pockets contain covalent-binding residues, suggesting that all ligands that targeting these pockets possess the potential to be modified into covalent ligands. To achieve this goal, we introduced CovalentLab, an interactive computational platform that integrates ligand-based and warhead-based strategies into a unified workflow for the rational design of covalent ligands. Leveraging a covalent binding site prediction model constructed on ESM-2 with LoRA fine-tuning, CovalentLab enables the prediction and ranking of nine classes of covalent-binding residues in proteins according to their reactivity and facilitates systematic warhead attachment to ligands using 210 electrophilic groups or user-defined warheads. Using this platform, a comprehensive library of more than 100,000 covalent molecules across 95 targets was generated. Notably, CovalentLab has been successfully applied to various essential real-world targets, identifying wet-laboratory-validated bioactive compounds ranging from TRK orthosteric inhibitors to GAC allosteric inhibitors. By bridging gaps in covalent drug discovery, CovalentLab offers a versatile, publicly accessible resource to expand the druggable targets and accelerate the development of targeted covalent therapies.

Schlagwörter

Stichwörter der Autor:innen

GACTRKcovalent design platformdatabasedeep learningpost-translational modificationsite predictionweb server

Autor:innen und Institutionen

  • State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100050, P. R. China.
  • Beijing Key Laboratory of Active Substances Discovery and Drugability Evaluation, Department of Medicinal Chemistry, Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, Bei…
  • Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang 310058, China.
  • Beijing Key Laboratory of Key Technologies for Preclinical Research and Development of Innovative Drugs in Pharmacokinetics and Pharmacodynamics, Beijing 100050, China.

ORCID-Profile: Tingjun Hou, Xiaojian Wang

Förderung

  • Chinese Academy of Medical Sciences
  • Peking Union Medical College Hospital
  • Natural Science Foundation of Beijing Municipality
  • Beijing Association for Science and Technology
  • National Natural Science Foundation of China
  • China Industrial Technology Infrastructure Public Service Platform Project

Zitieren

APA

Xue, X., Liu, X., Liu, X., Sun, H., Li, S., Chen, K., Xu, H., Li, L., Mao, C., Yan, J., Yang, P., Wang, B., Hou, T., Du, T., & Wang, X. (2025). One-Shot Rational Design of Covalent Drugs with CovalentLab. JACS Au, 5(11), 5676-5689. https://doi.org/10.1021/jacsau.5c01161

Vancouver

Xue X, Liu X, Liu X, Sun H, Li S, Chen K, et al. One-Shot Rational Design of Covalent Drugs with CovalentLab. JACS Au. 2025;5(11):5676-5689. doi:10.1021/jacsau.5c01161

BibTeX
@article{Xue2025,
  author = {Xue, Xi and Liu, Xiangying and Liu, Xue and Sun, Hanyu and Li, Shize and Chen, Kai and Xu, Hanmiao and Li, Liangning and Mao, Chengxia and Yan, Jingjie and Yang, Peilan and Wang, Baolian and Hou, Tingjun and Du, Tingting and Wang, Xiaojian},
  title = {One-Shot Rational Design of Covalent Drugs with CovalentLab},
  journal = {JACS Au},
  year = {2025},
  volume = {5},
  number = {11},
  pages = {5676--5689},
  doi = {10.1021/jacsau.5c01161}
}
Kostenlos starten →